Exciting news for our business partners 📣
We are pleased to announce our successful dossier readiness of Edoxaban 15 mg, 30 mg, and 60 mg FCT, marking a significant step forward in patient care. 💊
Discover how our innovation is reshaping anti-coagulation therapy. 🔬 Let’s collaborate to bring new possibilities to the patients. Contact us to explore partnership opportunities today!
Tomas Pilarcik, Nina Fuentes de Tienda, Rahul Padhye
#innovation #PartnershipOpportunities #zent2U #b2b
